Skip to main content

Advertisement

Table 2 Longitudinal development of prevalence rates (PR) and 95%-confidence interval (95%-CI) of insufficient physical activity (IPA)

From: Cross-sectional and longitudinal factors influencing physical activity of 65 to 75-year-olds: a pan European cohort study based on the survey of health, ageing and retirement in Europe (SHARE)

Male (n = 1760) Female (n = 2085)
  Wave 1 baseline* PR (95%-CI) Wave 2 2 years later PR (95%-CI) Wave 4 7 years later PR (95%-CI)   Wave 1 baseline* PR (95%-CI) Wave 2 2 years later PR (95%-CI) Wave 4 7 years later PR (95%-CI)
Countries     Countries    
Sweden (n = 206) 52.9% (46.1–59.7) 53.7% (46.9–60.5) 46.6% (39.8–53.4) Sweden (n = 256) 61.7% (55.7–67.7) 58.8% (52.8–64.8) 64.1% (58.2–70.0)
Denmark (n = 138) 47.1% (38.7–55.5) 55.1% (46.8–63.4) 59.1% (52.4–65.8) Denmark (n = 134) 48.5%** (40.0–57.0) 64.1% (55.9–72.3) 66.2% (58.2–74.2)
Netherlands (n = 193) 49.2% (42.1–56.3) 48.4% (41.3–55.5) 52.4% (45.3–59.5) Netherlands (n = 216) 55.6% (49.0–62.2) 47.9% (41.2–54.6) 59.5% (52.9–66.1)
Germany (n = 202) 42.1%** (35.3–48.9) 55.4% (48.5–62.3) 55.2%** (48.3–62.1) Germany (n = 196) 49.0%** (42.0–56.0) 60.2% (53.3–67.1) 55.4% (48.4–62.4)
Belgium (n = 279) 60.9% (55.2–66.6) 59.5% (53.7–65.3) 63.1% (57.4–68.8) Belgium (n = 345) 75.9% (71.4–80.4) 76.7% (72.2–81.2) 80.8% (76.6–85.0)
Austria (n = 95) 63.2% (53.5–72.9) 61.1% (51.2–71.0) 58.5%** (48.5–68.5) Austria (n = 122) 73.0% (65.1–80.9) 72.7% (64.8–80.6) 81.8%** (74.9–88.7)
Switzerland (n = 90) 42.2% (31.9–52.5) 42.2% (31.9–52.5) 53.3% (42.9–63.7) Switzerland (n = 105) 54.3% (44.7–63.9) 52.4% (42.8–62.0) 67.6% (58.6–76.6)
France (n = 158) 59.2% (51.5–66.9) 66.2% (58.8–73.6) 69.4% (62.2–76.6) France (n = 230) 77.8% (72.4–83.2) 80.3% (75.1–85.5) 80.0% (74.8–85.2)
Italy (n = 266) 63.5% (57.7–69.3) 66.5% (60.8–72.2) 73.2% (67.9–78.5) Italy (n = 311) 71.4% (66.4–76.4) 74.3% (69.4–79.2) 83.3% (79.1–87.5)
Spain (n = 134) 61.2% (52.9–69.5) 61.7% (53.4–70.0) 73.7% (66.2–81.2) Spain (n = 170) 68.0% (61.0–75.0) 66.3% (59.2–73.4) 82.1% (76.3–87.9)
Total (n = 1761) 54.9% (52.6–57.2) 57.8% (55.5–60.1) 60.9% (58.6–63.2) Total (n = 2085) 65.4% (63.4–67.4) 66.9% (64.9–68.9) 73.0% (71.1–74.9)
  1. *Age at baseline 58–68 years; ** Deviation of more than 5 percentage points from prevalence rates of all participants aged 65–75 years at wave 4 (see Additional file 1)